Yunglin Gazes1, Minghao Liu2, Melissa Sum3, Elaine Cong4, Jennifer Kuo5, James A Lee5, Shonni Silverberg4, Yaakov Stern1, Marcella Walker4. 1. Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA. 2. Division of Endocrinology, Department of Medicine, Hofstra Northwell School of Medicine at Hofstra University, Hempstead, New York, USA. 3. Division of Endocrinology, Department of Medicine, New York University Langone Medical Center, New York, New York, USA. 4. Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA. 5. Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA.
Abstract
OBJECTIVE: The neurophysiological mechanisms underlying cognitive dysfunction in primary hyperparathyroidism (PHPT) and the brain regions affected are not clear. We assessed neural activation during cognitive testing (matrix reasoning, paired associates, and logical memory) using functional MRI (fMRI) in 23 patients with PHPT and 23 healthy controls. A subset with PHPT was re-assessed 6 months post-parathyroidectomy (PTX). DESIGN: This is an observational study comparing neural activation by fMRI in patients with PHPT to normative controls. Postmenopausal women were studied at a tertiary referral center. RESULTS: There were no between-group differences in cognitive task performance. Patients with PHPT had lower neural activation vs controls (max Z = 4.02, all P < 0.01) during matrix reasoning in brain regions involved in executive function (left frontal lobe (k = 57) and right medial frontal gyrus (k = 72)) and motor function (right precentral gyrus (k = 51)). During paired associates (verbal memory), those with PHPT had greater activation in the right inferior parietal lobule (language/mathematical operations; k = 65, P < 0.01). Greater activation in this region bilaterally correlated with higher PTH (k = 96, P < 0.01). Post-PTX, activation decreased during matrix reasoning, but in different regions than those affected pre-PTX. CONCLUSIONS: PHPT is associated with differences in task-related neural activation patterns, but no difference in cognitive performance. While this may indicate compensation to maintain the same cognitive function, there was no clear improvement in neural activation after PTX. Larger, longitudinal studies that include PHPT patients followed without surgery are needed to determine if PTX could prevent worsening of altered neural activation patterns in PHPT.
OBJECTIVE: The neurophysiological mechanisms underlying cognitive dysfunction in primary hyperparathyroidism (PHPT) and the brain regions affected are not clear. We assessed neural activation during cognitive testing (matrix reasoning, paired associates, and logical memory) using functional MRI (fMRI) in 23 patients with PHPT and 23 healthy controls. A subset with PHPT was re-assessed 6 months post-parathyroidectomy (PTX). DESIGN: This is an observational study comparing neural activation by fMRI in patients with PHPT to normative controls. Postmenopausal women were studied at a tertiary referral center. RESULTS: There were no between-group differences in cognitive task performance. Patients with PHPT had lower neural activation vs controls (max Z = 4.02, all P < 0.01) during matrix reasoning in brain regions involved in executive function (left frontal lobe (k = 57) and right medial frontal gyrus (k = 72)) and motor function (right precentral gyrus (k = 51)). During paired associates (verbal memory), those with PHPT had greater activation in the right inferior parietal lobule (language/mathematical operations; k = 65, P < 0.01). Greater activation in this region bilaterally correlated with higher PTH (k = 96, P < 0.01). Post-PTX, activation decreased during matrix reasoning, but in different regions than those affected pre-PTX. CONCLUSIONS: PHPT is associated with differences in task-related neural activation patterns, but no difference in cognitive performance. While this may indicate compensation to maintain the same cognitive function, there was no clear improvement in neural activation after PTX. Larger, longitudinal studies that include PHPT patients followed without surgery are needed to determine if PTX could prevent worsening of altered neural activation patterns in PHPT.
Authors: Sanziana A Roman; Julie Ann Sosa; Linda Mayes; Eric Desmond; Leon Boudourakis; Rong Lin; Peter J Snyder; Elizabeth Holt; Robert Udelsman Journal: Surgery Date: 2005-12 Impact factor: 3.982
Authors: Sanziana A Roman; Julie Ann Sosa; Robert H Pietrzak; Peter J Snyder; Daniel C Thomas; Robert Udelsman; Linda Mayes Journal: Ann Surg Date: 2011-01 Impact factor: 12.969
Authors: John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts Journal: J Clin Endocrinol Metab Date: 2014-08-27 Impact factor: 5.958
Authors: C Habeck; Y Gazes; Q Razlighi; J Steffener; A Brickman; D Barulli; T Salthouse; Y Stern Journal: Neuroimage Date: 2015-10-31 Impact factor: 6.556
Authors: M Liu; M Sum; E Cong; I Colon; M Bucovsky; J Williams; A Kepley; J Kuo; J A Lee; R M Lazar; R Marshall; S Silverberg; M D Walker Journal: J Endocrinol Invest Date: 2019-10-16 Impact factor: 4.256
Authors: Manju Chandran; Lydia Tan Li Yeh; Mechteld C de Jong; John P Bilezikian; Rajeev Parameswaran Journal: Rev Endocr Metab Disord Date: 2022-08-22 Impact factor: 9.306